A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Descrição
Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent
Frontiers Publishing Partnerships
IJMS, Free Full-Text
IJMS, Free Full-Text
NK cells and their importance in cancer immunotherapy
Microparticles: biogenesis, characteristics and intervention
Membranes, Free Full-Text
Mitochondrial DNA-targeted therapy: A novel approach to combat
Meta analysis of bioactive compounds, miRNA, siRNA and cell death
Drugging the Undruggable genes - Enzo Life Sciences
Frontiers NK Cells in a Tug-of-War With Cancer: The Roles of
de
por adulto (o preço varia de acordo com o tamanho do grupo)